Hualan Biological Engineering Inc. (SHE: 002007)

Hualan Biological Engineering Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	4,911	5,333	4,503	4,426	5,016	3,691
Other Revenue	8.9	8.9	13.67	10.31	7.09	8.56
Revenue	4,920	5,342	4,517	4,436	5,023	3,700
Revenue Growth (YoY)	1.90%	18.26%	1.82%	-11.69%	35.76%	15.02%
Cost of Revenue	1,873	1,727	1,699	1,538	1,405	1,346
Gross Profit	3,046	3,615	2,818	2,898	3,618	2,354
Selling, General & Admin	1,229	1,465	1,205	1,011	1,328	737.87
Research & Development	274.9	280.84	314.7	253.63	213.21	143.54
Other Operating Expenses	56.02	44.62	41.75	36.17	37.29	31.65
Operating Expenses	1,541	1,805	1,595	1,312	1,621	919.41
Operating Income	1,505	1,810	1,223	1,586	1,997	1,434
Interest Expense	-15.25	-13.17	-30.27	-21.72	-4.97	-7.08
Interest & Investment Income	171	164.47	128.92	85.28	100.8	142.16
Currency Exchange Gain (Loss)	-0.3	-0.3	-0.01	0.33	0.3	0.01
Other Non Operating Income (Expenses)	-7.41	-0.28	-0.38	-0.34	-0.44	-0.24
EBT Excluding Unusual Items	1,653	1,961	1,322	1,650	2,093	1,569
Gain (Loss) on Sale of Investments	36.7	60.54	36.11	26.86	25.96	32.4
Gain (Loss) on Sale of Assets	0.85	44.44	47.67	0.42	-0.26	-0.01
Asset Writedown	-13.76	-9.71	-1.19	-3.23	-0.62	-1.67
Other Unusual Items	48.78	21.24	24.17	14.39	29.33	10.31
Pretax Income	1,726	2,078	1,428	1,688	2,147	1,610
Income Tax Expense	225.34	315.96	180.76	234.13	303.21	231.36
Earnings From Continuing Operations	1,501	1,762	1,248	1,454	1,844	1,379
Minority Interest in Earnings	-162.61	-280.11	-171.34	-155.22	-231.06	-95.43
Net Income	1,338	1,482	1,076	1,299	1,613	1,283
Net Income to Common	1,338	1,482	1,076	1,299	1,613	1,283
Net Income Growth	7.64%	37.66%	-17.14%	-19.48%	25.69%	12.63%
Shares Outstanding (Basic)	1,826	1,824	1,825	1,821	1,818	1,817
Shares Outstanding (Diluted)	1,830	1,824	1,828	1,831	1,820	1,818
Shares Change (YoY)	0.21%	-0.19%	-0.17%	0.59%	0.13%	0.24%
EPS (Basic)	0.73	0.81	0.59	0.71	0.89	0.71
EPS (Diluted)	0.73	0.81	0.59	0.71	0.89	0.71
EPS Growth	7.41%	37.92%	-17.00%	-19.95%	25.52%	12.37%
Free Cash Flow	436.05	592.43	563.36	621.15	703.85	1,090
Free Cash Flow Per Share	0.24	0.32	0.31	0.34	0.39	0.60
Dividend Per Share	0.300	0.300	0.300	0.200	0.300	0.308
Dividend Growth	0%	0%	50.00%	-33.33%	-2.50%	50.02%
Gross Margin	61.92%	67.67%	62.38%	65.33%	72.03%	63.62%
Operating Margin	30.60%	33.89%	27.08%	35.76%	39.76%	38.77%
Profit Margin	27.20%	27.74%	23.83%	29.28%	32.11%	34.69%
Free Cash Flow Margin	8.86%	11.09%	12.47%	14.00%	14.01%	29.45%
EBITDA	1,754	2,069	1,496	1,783	2,179	1,595
EBITDA Margin	35.65%	38.73%	33.12%	40.18%	43.38%	43.12%
D&A For EBITDA	248.37	258.71	272.5	196.39	181.66	160.9
EBIT	1,505	1,810	1,223	1,586	1,997	1,434
EBIT Margin	30.60%	33.89%	27.08%	35.76%	39.76%	38.77%
Effective Tax Rate	13.06%	15.21%	12.66%	13.87%	14.12%	14.37%
Revenue as Reported	4,920	5,342	4,517	4,436	5,023	3,700
Advertising Expenses	-	6.31	2.84	3.38	2.58	423.24

Source: S&P Capital IQ. Standard template. Financial Sources.